bg
A

Allovir (ALVR)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Allovir (ALVR)

AlloVir, Inc. is a late clinical-stage cell therapy company. The Company is engaged in developing allogeneic T-cell therapies to treat and prevent viral diseases. Its virus-specific T cell (VST) therapy platform enables to generate VSTs designed to r... Read more

  • USD1.53
  • USD1.56
  • USD1.49
  • USD7.84
  • 14.90%
  • --
  • 43.00
  • 852.87k
  • 177M
  • 1.31
  • -79.00%

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.